Skip to content

Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain

RecruitingNot applicableNCT06977100
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain and how much it interferes with daily life. The primary aims of this study are to: * Assess whether individuals with TMD and chronic overlapping pain are able to complete the 2-week gratitude journaling activity as planned (feasibility). * Evaluate how acceptable participants find the gratitude journaling activity (acceptability). The secondary aim of this study is to: • Explore whether the gratitude journaling activity reduces pain and its impact on daily life, compared to a general wellness journaling activity. Participants will: * Attend two in-person visits to complete questionnaires and take part in tests that measure how sensitive they are to pressure and heat. * Complete a 2-week journaling activity at home, writing in their journal on three days of their choice per week.

Study details

Official title
Examining the Feasibility and Acceptability of a Journaling Intervention in Alleviating Temporomandibular Pain
Conditions
  • Temporomandibular Disorders (TMD)
Interventions
  • Behavioral: Gratitude
  • Other: General Wellness
Sponsor
University of Florida
Start date
2025-08-11
Primary completion
2026-11
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * participants between the ages of 18 and 80 * pain in the temporomandibular (TMD) region (jaw and/or temple area) * duration of pain is at least 3 months * average pain score ≥4 on a 0-10 numerical rating scale over the past week * have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis. * able to read, understand, and write in English. Exclusion Criteria: * history of TMD surgery * neoplasm or injury/trauma to the TMD area * cancer-related pain * scheduled for any surgeries during the study time-frame * current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes * pregnant or lactating * severe motor impairments (e.g., muscular dystrophy) * severe psychiatric conditions (e.g., uncontrolled mood disorders) * severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease) * any other conditions that in the opinion of study investigators could make participation in the study unsafe * use of opioids within 48 hours prior to laboratory visit

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06977100